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Adaptive thermogenesis: Turning on the heat
Bradford B. Lowell
Brown adipocytes play important roles in the regulation
of fat storage and body temperature, by virtue of their
ability to uncouple mitochondrial fuel oxidation and
ATP synthesis. The discovery of a tissue-specific
transcriptional coactivator provides new insights into
the regulation of thermogenesis by brown adipocytes.
Address: Beth Israel Deaconess Medical Center and Harvard Medical
School, Division of Endocrinology, Department of Medicine, 330
Brookline Avenue, Boston, Massachusetts 02215, USA.
E-mail: blowell@bidmc.harvard.edu
Current Biology 1998, 8:R517–R520
http://biomednet.com/elecref/09609822008R0517
© Current Biology Ltd ISSN 0960-9822
Brown adipocytes are highly specialized cells with a
marked capacity for regulated thermogenesis. This feature
is largely due to their abundant mitochondria, which
uniquely possess the ability to uncouple fuel oxidation
from ATP production, thus generating heat. Thermogene-
sis by adipocytes is a regulated, adaptive phenomenon —
it is dramatically promoted by various agents, such as
β-adrenergic receptor agonists, thyroid hormone, retinoic
acid and ligands for peroxisome proliferator-activated
receptor γ (PPARγ). The signaling pathways for these
agents, however, also operate in other cell types — most
notably non-thermogenic white adipocytes — and the
downstream transcriptional mechanism that allows brown
adipocytes to switch on their thermogenic machinery has
until recently been unknown. But now Puigserver et al. [1]
have reported the identification of an important link in the
pathway that induces thermogenesis in brown adipocytes
— a tissue-specific nuclear receptor coactivator known as
PPAR gamma coactivator-1 (PGC-1).
Regulated heat production plays an important part in the
general control of the body’s energy budget. Triglyceride is
an efficient means of storing energy, and its accumulation
in white adipose tissue permits survival during starvation.
Excessive fat storage, as in obesity, however, adversely
affects health by increasing the risk of non-insulin-depen-
dent diabetes mellitus and cardiovascular disease. In order
to maintain proper balance, organisms must regulate fat
storage. The brain plays a central role in controlling this
process; it receives afferent inputs conveying information
about nutritional status, integrates these signals and then
modulates food intake and a component of energy expendi-
ture that is referred to as adaptive thermogenesis. 
In rodents, brown adipose tissue makes an important
contribution to adaptive thermogenesis [2]. This highly
specialized tissue (Figure 1) is distinguished by its intense
sympathetic innervation, extensive blood supply, abun-
dant mitochondria and unique expression of uncoupling
protein-1 (UCP1). UCP1 is an inner mitochondria mem-
brane carrier with proton transport activity which dissi-
pates the proton electrochemical potential gradient,
uncoupling fuel oxidation from conversion of ADP to ATP
[3]. Consequently, stimulated brown adipocytes consume
fuels, with the major by-product being the generation of
heat. Recently, two proteins related to UCP1 were identi-
fied, UCP2 [4] and UCP3 [5], which are approximately
57% identical in amino-acid sequence to UCP1. UCP2 is
widely expressed, whereas UCP3 is found preferentially
in skeletal muscle. Whether these UCP1 homologs also
act as mitochondrial uncoupling proteins is presently
under investigation.
Figure 1
Electron micrograph of brown fat from a cold-exposed mouse. Note
the abundant mitochondria with densely packed cristae (micrograph
kindly provided by Saverio Cinti).
As UCP1 is expressed exclusively in brown adipocytes,
intense interest has focused on transcription factors that
regulate UCP1 production. The hope has been that the
identification of such factors will shed important new light
on the pathway of adaptive thermogenesis. Indeed, these
efforts have identified a complex 220 base-pair enhancer,
located approximately 2.4 kilobases upstream of the
mouse [6] and rat UCP1 genes [7], which mediates brown-
adipocyte-specific expression of UCP1, as well as induc-
tion by β-adrenergic receptor agonists (via the second
messenger cAMP), thyroid hormone [8,9], retinoic acid
[10] and ligands for PPARγ [11]. As none of these signal-
ing pathways is unique to brown adipocytes, however, the
basis for development of the brown-adipocyte-specific
thermogenic phenotype has been an enigma.
There is particular interest in PPARγ, a ligand-activated
transcription factor related to the steroid hormone recep-
tors, which has recently been identified as a regulator of
UCP1 gene expression and brown fat development.
PPARγ is expressed at highest levels in white and brown
adipose tissue. In white adipose tissue, PPARγ plays a
critical role, along with the transcription factor C/EBPα, in
promoting the differentiation of white adipocytes [12].
Furthermore, PPARγ is activated by thiazolidinediones,
synthetic ligands which potently increase insulin respon-
siveness in animals — including humans — with non-
insulin-dependent diabetes mellitus [13]. The physiologic
mechanism responsible for this important therapeutic
effect is presently unknown, but it may be related to
effects on brown fat development and function.
Over ten years ago, before the discovery of PPARγ, it was
noted that thiazolidinediones stimulate brown fat thermo-
genesis [14,15]. More recently, it was shown that thiazo-
lidinediones induce terminal differentiation of brown
adipocyte cell lines [16]. Importantly, it was found that
PPARγ binds to the UCP1 enhancer, from which it can
activate transcription when coexpressed in cultured brown
preadipocytes with its obligate heterodimerizing partner,
the retinoid X receptor (RXR) [11]. Interestingly, transac-
tivation of the UCP1 enhancer does not occur in non-
adipocyte fibroblastic cell lines, indicating that additional
factors must be present for brown-adipocyte-specific
UCP1 expression. This is consistent with the observation
that white adipocytes, while expressing significant
amounts of PPARγ, lack UCP1 and other characteristic
features of thermogenic brown adipocytes.
PPARγ, like other nuclear receptors, stimulate transcription
via interactions with coactivators, such as steroid receptor
coactivator-1 (SRC-1) [17,18]. For the most part, these coac-
tivators are widely expressed and consequently have not
been thought to be important determinants of tissue-spe-
cific responses. With this in mind, it is of significance that
Puigserver et al. [1] have cloned PGC-1, a coactivator with
relative tissue specificity. PGC-1 is expressed in brown fat,
heart, muscle, kidney and brain, but not in many other
tissues, most notably, white fat. Importantly, PGC-1 mRNA
levels are dramatically upregulated in brown fat and skele-
tal muscle following acute cold exposure, which is a potent
stimulator of sympathetic nervous outflow to brown fat.
Numerous previous studies have shown that cold exposure
markedly increases UCP1 gene expression, mitochondrial
biogenesis, hyperplasia and thermogenesis in brown fat [2].
PGC-1 is a novel protein which shares little homology
with previously identified coactivators. Its gene was
cloned using the yeast two-hybrid assay with part of
mouse PPARγ as bait. In cell-free protein–protein interac-
tion assays, PGC-1 associates strongly with PPARγ and
also the thyroid hormone, retinoic acid and estrogen
receptors, but only weakly or not at all with the RXR. The
binding of PGC-1 to PPARγ has two unusual features.
First, the interaction is not ligand dependent — binding
occurs with or with out the addition of PPARγ ligands. In
contrast, modest to strong ligand dependence was found
for the binding of PGC-1 to the thyroid hormone, retinoic
acid and estrogen receptors. Second, PGC-1 binds to the
DNA-binding and hinge domains of PPARγ, not the
classical AF-2 domain which interacts with other coactiva-
tors such as SRC-1 [17,18]. As noted by Puigserver et al.
[1], this raises the interesting possibility that PPARγ inter-
acts simultaneously with PGC-1 and other coactivators to
generate a larger, synergistically active macromolecular
complex (Figure 2). 
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Figure 2
A possible mechanism by which PGC-1 might increase the
transcriptional activation potency of PPARγ. PPARγ and RXR form
heterodimers on a PPARγ response element in the UCP1 enhancer.
PGC-1 contacts the DNA-binding and hinge domains of PPARγ, while
other coactivators, such as SRC-1 and possibly CBP, bind to its AF-2
domain. These coactivators increase ligand dependent gene
transcription. The ligand for RXR is 9-cis retinoic acid; PPARγ ligands
include the synthetic, antidiabetic thiazolidinediones, as well as
various natural ligands, including 15-deoxy-prostaglandin J2 and
certain free fatty acids.
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In transient transfection assays, PGC-1 greatly augments
the ability of both PPARγ and the thyroid hormone recep-
tor to activate transcription from the UCP1 promoter.
Interestingly, the combined transcriptional activation
potency of PGC-1 and PPARγ was increased further by
the addition of cAMP analogues. This agrees with earlier
observations that β-adrenergic receptor agonists, which
increase intracellular cAMP levels, and thiazolidinediones
synergistically increase UCP1 mRNA expression in cul-
tured brown adipocytes [19]. Similarly, cAMP synergizes
with thyroid hormone to increase UCP1 gene expression
[9]. It is not known whether the effects of cAMP on UCP1
gene expression are mediated by the cAMP response
element binding protein (CREB). It is possible that PGC-
1, by virtue of its three potential protein kinase A phos-
phorylation sites, directly mediates the stimulatory effects
of cAMP. This attractive possibility could account for the
synergistic actions of cAMP on the activation of UCP1
gene expression that is induced by thiazolidinedione or
thyroid hormone.
Perhaps the most compelling argument for an involve-
ment of PGC-1 in adaptive thermogenesis comes from the
effects of retrovirally-mediated, chronic overexpression of
PGC-1 in cultured white fat cells (3T3-F442A cells) [1].
Normally, these cells make little or no PGC-1 and UCP1,
and have few mitochondria. The induced overexpression
of PGC-1 led to an increase in the levels of mRNAs for
UCP1, ATP synthase and cytochrome c-oxidase subunit
Cox-IV, which are encoded by the nuclear genome, and
also for cytochrome c-oxidase subunit Cox-II, which is
encoded by the mitochondrial genome. PGC-1-expressing
cells also had increased levels of mitochondrial DNA, indi-
cating that overall mitochondrial biogenesis had been
stimulated. The mechanism by which PGC-1 increases
expression of genes encoded by the mitochondrial
genome, such as Cox-II, and mitochondrial biogenesis in
general, remains to be determined, but it might involve
regulation of genes involved in communication between
nucleus and mitochondria [20]. Overall, the observed
effects of ectopic PGC-1 expression are impressive, espe-
cially as the level of PGC-1 expression achieved in the cul-
tured white adipocytes was only 6% of that observed in
brown adipose tissue from cold-exposed animals.
Finally, we are left with the following perplexing ques-
tion: how does a coactivator like PGC-1 confer specificity?
PPARγ, in addition to being expressed in brown
adipocytes, is also abundantly expressed in white
adipocytes, where it plays an important role in driving
expression of aP2 [12], which encodes a fatty-acid-binding
protein. White adipocytes must have potent PPARγ coac-
tivators, though not PGC-1. If transcription factors and
coactivators are completely modular and interchangeable,
as years of domain-swap experiments have taught us, how
is it that these coactivators in white adipocytes stimulate
PPARγ-mediated transcription of aP2, but not UCP1?
Puigserver et al. [1] found that ectopic overexpression of
PGC-1 in white fat cells increased expression of UCP1, but
not aP2. Again, if all components of the system are
modular and independent, then why is it that ectopic
expression of PGC-1 fails to increase aP2 expression? 
One possible explanation for the specificity of PGC-1 for
UCP1 over aP2 is that it interacts simultaneously with a
number of transcription factors assembled on the UCP1
promoter, including PPARγ and the thyroid hormone and
retinoic acid receptors, to produce a cumulative potent
effect on UCP1 gene transcription (Figure 2). Alterna-
tively, PPARγ response element of UCP1, but not that of
aP2, may induce specific conformational changes in
PPARγ that permit interaction with PGC-1. Examples of
such interactions between DNA binding sites and
transcription factors have recently been reviewed [21].
Overall, the evidence is persuasive that the PGC-1 is an
important missing link between signaling pathways that
are not tissue-specific and induction of the brown-fat-
specific thermogenic phenotype.
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